These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11600348)

  • 1. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
    Dreses-Werringloer U; Padubrin I; Zeidler H; Köhler L
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3001-8. PubMed ID: 11600348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro model of azithromycin-induced persistent Chlamydia trachomatis infection.
    Xue Y; Zheng H; Mai Z; Qin X; Chen W; Huang T; Chen D; Zheng L
    FEMS Microbiol Lett; 2017 Aug; 364(14):. PubMed ID: 28854672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin.
    Wyrick PB; Knight ST
    J Antimicrob Chemother; 2004 Jul; 54(1):79-85. PubMed ID: 15163653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.
    Renault CA; Israelski DM; Levy V; Fujikawa BK; Kellogg TA; Klausner JD
    Sex Health; 2011 Mar; 8(1):69-73. PubMed ID: 21371385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.
    Toti US; Guru BR; Hali M; McPharlin CM; Wykes SM; Panyam J; Whittum-Hudson JA
    Biomaterials; 2011 Sep; 32(27):6606-13. PubMed ID: 21652065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection.
    Shao L; You C; Cao J; Jiang Y; Liu Y; Liu Q
    Int J Infect Dis; 2020 Jul; 96():121-127. PubMed ID: 32173573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion.
    Giles DK; Whittimore JD; LaRue RW; Raulston JE; Wyrick PB
    Microbes Infect; 2006 May; 8(6):1579-91. PubMed ID: 16698305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
    Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
    DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
    Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
    Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.
    Gieffers J; Füllgraf H; Jahn J; Klinger M; Dalhoff K; Katus HA; Solbach W; Maass M
    Circulation; 2001 Jan; 103(3):351-6. PubMed ID: 11157684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
    Roblin PM; Reznik T; Kutlin A; Hammerschlag MR
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1135-6. PubMed ID: 12604555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
    Bhengraj AR; Srivastava P; Mittal A
    Int J Antimicrob Agents; 2011 Aug; 38(2):178-9. PubMed ID: 21570258
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis.
    Wyrick PB; Davis CH; Raulston JE; Knight ST; Choong J
    Clin Infect Dis; 1994 Nov; 19(5):931-6. PubMed ID: 7893882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections.
    Mishra MK; Kotta K; Hali M; Wykes S; Gerard HC; Hudson AP; Whittum-Hudson JA; Kannan RM
    Nanomedicine; 2011 Dec; 7(6):935-44. PubMed ID: 21658474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.
    Carter JD; Espinoza LR; Inman RD; Sneed KB; Ricca LR; Vasey FB; Valeriano J; Stanich JA; Oszust C; Gerard HC; Hudson AP
    Arthritis Rheum; 2010 May; 62(5):1298-307. PubMed ID: 20155838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ
    J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.
    Dreses-Werringloer U; Padubrin I; Jürgens-Saathoff B; Hudson AP; Zeidler H; Köhler L
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3288-97. PubMed ID: 11083629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.